bta takeover very possible, page-25

dday

Biota allow Glaxo to set any price.

They will argue that is in Glaxo's interest to sell at a high price - that is obvious.

In the case of various publicity recently by Glaxo around max Relenza production, plus the recent negotiations with British govts (and others) for return of Antivirals, together with statements that they have negotiated sales of Relenza to these govts, do you think that a total of $2m of sales last quarter in Europe makes sense?

Wilson HTM have made the comment that Glaxo may have discounted Relenza.

If you put 2 + 2 together, I think this is the case.